Loading...
XASE
RGNT
Oct 08, Last price  
1.70USD
1D
4.29%
1Q
-55.15%
IPO
-77.33%
Name

Regentis Biomaterials Ltd

Chart & performance

D1W1MN
XASE:RGNT chart
P/E
—
P/S
—
EPS
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Key people

Chairman of the Board · since 2007
Eli Hazum
Chief Executive Officer · since 2021
Arie Gordashnikov
Chief Financial Officer · since 2022
Jeff Dykan
Director · since 2005
Independent Director Nominee
Pini Ben-Elazar
Independent Director Nominee
Efraim Cohen-Arazi
Independent Director Nominee
Independent Director · since 2015
IPO date
Nov 26, 2025
Employees
Domiciled in
IL
Incorporated in
IL

Valuation

No data to show